Q1 2025 Merck KGaA Earnings Call Transcript

Author's Avatar
May 15, 2025

May 15, 2025 / 12:00PM GMT
Operator

Dear ladies and gentlemen, welcome to the Merck investor and analyst conference call on first quarter 2025. (Operator Instructions)

I am now handing over to Florian Schraeder, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.

Florian Schraeder - Merck KGaA - Head of Investor Relations

Thank you so much, Heidi. And a very warm welcome to this Merck Q1 '25 results call. My name is Florian Schraeder. I'm the Head of Investor Relations here at Merck.

I'm delighted to be joined today by Belén Garijo, our Group CEO; as well as Helene von Roeder, our Group CFO. For the Q&A part of this call, we will also have Matthias Heinzel, CEO, Life Science; Jean-Charles Wirth, Designated CEO, Life Science; Peter Guenter, CEO, Healthcare; Danny Bar-Zohar, Designated CEO, Healthcare; as well as Kai Beckmann, CEO, Electronics.

In the first couple of minutes of this call, we would like to guide you through the key slides of the presentation. After that, we will be more than happy to take your questions.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot